Aura Biosciences, Inc.

NASDAQ:AURA

8.2 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 25.40730.07526.27941.08255.58447.73238.492121.58261.1153.849108.382149.06381.82992.19799.69317.393
Short Term Investments 148.97157.341176.595185.08793.472114.281135.0367.22950.40968.28224.89900000
Cash and Short Term Investments 174.377187.416202.874226.169149.056162.013173.522188.811111.519122.131133.281149.06381.82992.19799.69317.393
Net Receivables 0000000000000000
Inventory 0000000000000000
Other Current Assets 9.1048.189.3755.6444.8324.1985.5997.8914.3895.5386.3014.6411.6290.6781.0471.062
Total Current Assets 183.481195.596212.249231.794153.888166.211179.121196.702115.908127.669139.582153.70483.45892.875100.72118.455
Non-Current Assets:
Property, Plant & Equipment, Net 21.06921.47521.55522.00424.42525.0625.50726.04226.4716.4596.7156.2015.5385.3184.3063.574
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 0000000000000000
Long Term Investments 00.7680.7680.7680.7680.7680.7680.7680.7680.8930.1250.1250.1250.1250.0750
Tax Assets 0000000000000000
Other Non-Current Assets 0.790.4430.4530.5090.6850.70.6230.42300001.5830.33500.075
Total Non-Current Assets 21.85922.68622.77623.28125.87826.52826.89827.23327.2397.3526.846.3267.2465.7784.3813.649
Total Assets 205.34218.282235.025255.075179.766192.739206.019223.935143.147135.021146.422160.0390.70498.653105.10222.104
Liabilities & Equity:
Current Liabilities:
Account Payables 1.9911.4591.9331.7871.490.5531.0552.9211.7241.1981.9562.4011.7362.4171.3110.611
Short Term Debt 3.1262.7545.4825.3746.076.0165.975.9265.8841.2661.2481.231.2140.6010.3680.015
Tax Payables 0000000000000000
Deferred Revenue 00005.3494.5680003.48103.8332.7531.94501.773
Other Current Liabilities 9.5976.3352.2485.1963.3342.3261.0821.612.3563.3481.7993.6412.8812.2981.7422.035
Total Current Liabilities 14.71410.5489.66312.35710.8948.8958.10710.4579.9645.8125.0037.2725.8315.3163.4212.661
Non-Current Liabilities:
Long Term Debt 15.95816.2816.57916.8717.15417.40717.65417.89518.1290.0510.2060.360.5130.6610.4940
Deferred Revenue Non-Current 0000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000
Other Non-Current Liabilities 0000000000.0670.127016.649215.4270.068128.156
Total Non-Current Liabilities 15.95816.2816.57916.8717.15417.40717.65417.89518.1290.1180.3330.44317.162216.0880.562128.156
Total Liabilities 30.67226.82826.24229.22728.04826.30225.76128.35228.0935.935.3367.71522.993221.4043.983130.817
Equity:
Preferred Stock 000000000000198.726215.304215.309128.076
Common Stock 0000000000000000
Retained Earnings -348.393-327.351-307.014-287.308-265.177-246.665-228.366-210.9-194.341-178.44-164.972-152.137-140.503-131.665-122.813-116.886
Accumulated Other Comprehensive Income/Loss 0.607-0.1830.0180.539-0.134-0.223-0.045-0.072-0.147-0.128-0.00500000
Other Total Stockholders Equity 522.454518.988515.779512.617417.029413.325408.669406.555309.542307.659306.063304.45226.066-206.398.623-119.903
Total Shareholders Equity 174.668191.454208.783225.848151.718166.437180.258195.583115.054129.091141.086152.31567.711-122.751101.119-108.713
Total Equity 174.668191.454208.783225.848151.718166.437180.258195.583115.054129.091141.086152.31567.711-122.751101.119-108.713
Total Liabilities & Shareholders Equity 205.34218.282235.025255.075179.766192.739206.019223.935143.147135.021146.422160.0390.70498.653105.10222.104